Pulmonx Reports Record Third Quarter 2023 Financial Results
October 30, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023
October 16, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue
October 10, 2023 16:05 ET
|
Pulmonx Corporation
Derrick Sung steps down from his position as Chief Financial Officer to pursue another opportunity; John McKune appointed Interim Chief Financial OfficerPreliminary, unaudited third quarter 2023...
Pulmonx to Participate at Upcoming Investor Conferences
August 30, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx Reports Second Quarter 2023 Financial Results
August 02, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced...
Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023
July 17, 2023 08:00 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Reports First Quarter 2023 Financial Results
May 02, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference
April 25, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...